Court Nixes Bid To Boot Lead Avandia Plaintiff
A fight between institutional investors vying for the role of lead plaintiff in a shareholder lawsuit over GlaxoSmithKline's troubled diabetes drug Avandia has ended in a victory for Avon Pension Fund,...To view the full article, register now.
Already a subscriber? Click here to view full article